HTG Molecular Diagnostics Achieves ISO 13485:2003 Certification

HTG Molecular Diagnostics Achieves ISO 13485:2003 Certification

ID: 169628

Demonstrating Internationally Recognized Standards for Quality Management in Provision of Medical Devices and Related Services


(firmenpresse) - TUCSON, AZ -- (Marketwire) -- 07/30/12 -- HTG Molecular Diagnostics, a privately-held company providing products for gene expression profiling, has achieved ISO 13485:2003 certification for the design, manufacture, and distribution of instruments, software, reagents and test kits used in the analysis of gene expression. The certification covers the design, development, production, and sale of the patented qNPA technology-based products and services in HTG Molecular Diagnostics' portfolio.

To earn this internationally recognized quality standard certification, an organization is required to demonstrate it has quality management systems in place to consistently meet customer and regulatory requirements for design and development of medical devices.

"The achievement of the ISO 13485:2003 certification demonstrates HTG Molecular Diagnostics' commitment to quality and attention to detail in the development and provision of qNPA technology-based products and services, laying a solid foundation for the future growth of HTG's clinical diagnostics business," stated Sam Rua, Vice President of Regulatory Affairs and Quality Systems at HTG Molecular Diagnostics.

HTG Molecular Diagnostics is a privately-held, Tucson-based company providing products for gene expression profiling, miRNA and mRNA measurement for clinical research, early drug discovery companion diagnostic and prognostic applications in oncology. The company's qNPA molecular technology platform is well-suited for reliably detecting changes in gene expression levels especially from formalin-fixed, paraffin-embedded (FFPE) tissue. Additional information is available at .





Kimberly Schmitz
Spur Public Relations
520.247.5778


TJ Johnson
Chief Executive Officer
HTG Molecular Diagnostics
520.547.2827



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  ProMetic Life Sciences and NantPharma, a NantWorks Company, to Develop and Commercialize Plasma-Derived Biopharmaceuticals Horizon Pharma to Host Conference Call and Webcast to Discuss Second Quarter 2012 Financial Results on August 10, 2012
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 30.07.2012 - 11:00 Uhr
Sprache: Deutsch
News-ID 169628
Anzahl Zeichen: 0

contact information:
Town:

TUCSON, AZ



Kategorie:

Biotech



Diese Pressemitteilung wurde bisher 264 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"HTG Molecular Diagnostics Achieves ISO 13485:2003 Certification"
steht unter der journalistisch-redaktionellen Verantwortung von

HTG Molecular Diagnostics (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von HTG Molecular Diagnostics



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z